Dow Jones (DJIA) Today: Goldman Sachs Group (GS) Higher

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer..

The Dow Jones Industrial Average ( ^DJI) is trading up 121 points (+0.7%) at 18,162 as of Wednesday, May 27, 2015, 11:36 a.m. ET. During this time, 91.7 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 360.1 million. The NYSE advances/declines ratio sits at 1,885 issues advancing vs. 1,054 declining with 175 unchanged.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

The Dow component leading the way higher looks to be Goldman Sachs Group (NYSE: GS), which is sporting a $1.76 gain (+0.8%) bringing the stock to $208.14. This single gain is lifting the Dow Jones Industrial Average by 13.32 points or roughly accounting for 11% of the Dow's overall gain. Volume for Goldman Sachs Group currently sits at 888,076 shares traded vs. an average daily trading volume of 2.4 million shares.

Goldman Sachs Group has a market cap of $89.77 billion and is part of the financial sector and financial services industry. Shares are up 6.5% year-to-date as of Tuesday's close. The stock's dividend yield sits at 1.3%.

The Goldman Sachs Group, Inc. operates as an investment banking, securities, and investment management company worldwide. The company operates through four segments: Investment Banking, Institutional Client Services, Investing & Lending, and Investment Management.

If you liked this article you might like

China's Banks Halt Business With North Korea Per United Nations Sanctions

Why Hurricanes Won't Force the Fed to Ditch a December Rate Hike

Fed Pares $4.5 Trillion Balance Sheet But Easy-Money Era Isn't Over

Bank Stocks Move Higher as Fed Decides to Start Unwinding Balance Sheet

Cramer: Goldman's Downgrade Of J&J Is 'Questionable'